GSA Capital Partners’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $34K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $86K | Buy |
|
|||||
|
2023
Q1 | $45K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $443K | Buy |
|
|||||
|
2021
Q4 | $789K | Buy |
|
|||||
|
2021
Q3 | $493K | Sell |
|
|||||
|
2021
Q2 | $768K | Buy |
|
|||||
|
2021
Q1 | $485K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $192K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $186K | Sell |
|
|||||
|
2019
Q1 | $352K | Sell |
|
|||||
|
2018
Q4 | $293K | Sell |
|
|||||
|
2018
Q3 | $969K | Buy |
|
|||||
|
2018
Q2 | $400K | Sell |
|
|||||
|
2018
Q1 | $1.41M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $240K | Buy |
|